Market Overview:
The global cardiopulmonary autotransfusion equipment market is expected to grow at a CAGR of 5.5% during the forecast period from 2018 to 2030. The growth in this market can be attributed to the increasing incidence of cardiovascular diseases, rising geriatric population, and technological advancements in autotransfusion devices. Based on type, the global cardiopulmonary autotransfusion equipment market is segmented into unwashed ATS and washed ATS. The unwashed ATS segment is expected to account for a larger share of the market than the washed ATS segment during the forecast period. This can be attributed to its low cost and easy availability as compared to washed ATS devices. Based on application, the global cardiopulmonary autotransfusion equipment market is divided into heart surgery, great organ transplant surgery, and other surgeries (including neurosurgery, orthopedic surgery etc.).
Product Definition:
CARDIOPULMONARY AUTOTRANSPLANTATION EQUIPMENT is a device that is used to transfuse blood from the patient's own circulatory system back into the patient's body. The equipment is used to improve the oxygenation of blood and to prevent or treat tissue damage caused by lack of oxygen.
Unwashed ATS:
Unwashed ATS (Autotransfusion System) is a new concept of blood storage and transfusion technology. It's main objective is to store whole blood for later use in case of an emergency situation, such as hemorrhage or bleeding. The system uses no detergents, anticoagulants or additives other than the RBCs (Red Blood Cells). These are used to maintain the integrity of stored blood.
Washed ATS:
Washed ATS (WATTS) is a blood storage device that helps in the collection, processing, and storage of whole blood. It reduces contamination risks and provides high-quality stored products. The WATTS system includes components such as bags, filters, separation membranes/filtration membrane systems or plasma separators which are used for autotransfusion therapy in ICU settings.
Application Insights:
The heart surgery segment dominated the global cardiopulmonary autotransfusion equipment market in 2017 and is expected to witness lucrative growth during the forecast period. This can be attributed to a rising number of patients suffering from cardiac arrest outside hospitals, which forces them to undergo life-saving procedures at the scene of accidents or in remote areas. In such cases, it becomes important for healthcare professionals operating on such patients¢â‚¬â„¢ hearts to use automated devices that help reduce human errors and ensure high standards of safety.
In addition, key players have developed innovative products with features such as washable filters that are designed specifically for single use by surgeons during open heart surgeries so as not to get contaminated with blood or other fluids subsequently discarded by the body.
Regional Analysis:
North America dominated the global cardiopulmonary autotransfusion equipment market in 2017. This can be attributed to increasing incidence of heart diseases, rising number of surgeries and growing demand for organ transplantation procedures. According to the American Heart Association, around 6.3 million people suffer from heart-related problems each year in U.S.
Growth Factors:
- Increasing incidence of cardiovascular diseases: The increasing incidence of cardiovascular diseases is one of the key growth drivers for the cardiopulmonary autotransfusion equipment market. According to the World Health Organization, an estimated 17.9 million people died from cardiovascular diseases in 2012, which accounted for 31% of all global deaths. This number is expected to increase to 23.3 million by 2030. This will create a high demand for cardiopulmonary autotransfusion equipment and drive the market growth during the forecast period.
- Technological advancements: The technological advancements in cardiopulmonary autotransfusion equipment are another major driver for this market. With continuous innovations and developments taking place in this field, manufacturers are introducing new and advanced products in the market that offer better performance and efficiency than their predecessors do. This is helping to boost demand for these devices and is propelling market growth globally
Scope Of The Report
Report Attributes
Report Details
Report Title
Cardiopulmonary Autotransfusion Equipment Market Research Report
By Type
Unwashed ATS, Washed ATS
By Application
Heart Surgery, Great Organ Transplant Surgery, Other Surgery
By Companies
Haemonetics, Medtronic, LivaNova, Fresenius Kabi, Terumo, Wandong Health Sources, Haemonetics
Regions Covered
North America, Europe, APAC, Latin America, MEA
Base Year
2021
Historical Year
2019 to 2020 (Data from 2010 can be provided as per availability)
Forecast Year
2030
Number of Pages
164
Number of Tables & Figures
115
Customization Available
Yes, the report can be customized as per your need.
Global Cardiopulmonary Autotransfusion Equipment Market Report Segments:
The global Cardiopulmonary Autotransfusion Equipment market is segmented on the basis of:
Types
Unwashed ATS, Washed ATS
The product segment provides information about the market share of each product and the respective CAGR during the forecast period. It lays out information about the product pricing parameters, trends, and profits that provides in-depth insights of the market. Furthermore, it discusses latest product developments & innovation in the market.
Applications
Heart Surgery, Great Organ Transplant Surgery, Other Surgery
The application segment fragments various applications of the product and provides information on the market share and growth rate of each application segment. It discusses the potential future applications of the products and driving and restraining factors of each application segment.
Some of the companies that are profiled in this report are:
- Haemonetics
- Medtronic
- LivaNova
- Fresenius Kabi
- Terumo
- Wandong Health Sources
- Haemonetics
Highlights of The Cardiopulmonary Autotransfusion Equipment Market Report:
- The market structure and projections for the coming years.
- Drivers, restraints, opportunities, and current trends of market.
- Historical data and forecast.
- Estimations for the forecast period 2030.
- Developments and trends in the market.
- By Type:
- Unwashed ATS
- Washed ATS
- By Application:
- Heart Surgery
- Great Organ Transplant Surgery
- Other Surgery
- Market scenario by region, sub-region, and country.
- Market share of the market players, company profiles, product specifications, SWOT analysis, and competitive landscape.
- Analysis regarding upstream raw materials, downstream demand, and current market dynamics.
- Government Policies, Macro & Micro economic factors are also included in the report.
We have studied the Cardiopulmonary Autotransfusion Equipment Market in 360 degrees via. both primary & secondary research methodologies. This helped us in building an understanding of the current market dynamics, supply-demand gap, pricing trends, product preferences, consumer patterns & so on. The findings were further validated through primary research with industry experts & opinion leaders across countries. The data is further compiled & validated through various market estimation & data validation methodologies. Further, we also have our in-house data forecasting model to predict market growth up to 2030.
Regional Analysis
- North America
- Europe
- Asia Pacific
- Middle East & Africa
- Latin America
Note: A country of choice can be added in the report at no extra cost. If more than one country needs to be added, the research quote will vary accordingly.
The geographical analysis part of the report provides information about the product sales in terms of volume and revenue in regions. It lays out potential opportunities for the new entrants, emerging players, and major players in the region. The regional analysis is done after considering the socio-economic factors and government regulations of the countries in the regions.
How you may use our products:
- Correctly Positioning New Products
- Market Entry Strategies
- Business Expansion Strategies
- Consumer Insights
- Understanding Competition Scenario
- Product & Brand Management
- Channel & Customer Management
- Identifying Appropriate Advertising Appeals
8 Reasons to Buy This Report
- Includes a Chapter on the Impact of COVID-19 Pandemic On the Market
- Report Prepared After Conducting Interviews with Industry Experts & Top Designates of the Companies in the Market
- Implemented Robust Methodology to Prepare the Report
- Includes Graphs, Statistics, Flowcharts, and Infographics to Save Time
- Industry Growth Insights Provides 24/5 Assistance Regarding the Doubts in the Report
- Provides Information About the Top-winning Strategies Implemented by Industry Players.
- In-depth Insights On the Market Drivers, Restraints, Opportunities, and Threats
- Customization of the Report Available
Frequently Asked Questions?
Cardiopulmonary autotransfusion equipment is a medical device used to provide blood and other fluids to patients with cardiac arrest.
Some of the key players operating in the cardiopulmonary autotransfusion equipment market are Haemonetics, Medtronic, LivaNova, Fresenius Kabi, Terumo, Wandong Health Sources, Haemonetics.
The cardiopulmonary autotransfusion equipment market is expected to register a CAGR of 5.5%.
Chapter 1 Executive Summary
Chapter 2 Assumptions and Acronyms Used
Chapter 3 Research Methodology
Chapter 4 Cardiopulmonary Autotransfusion Equipment Market Overview
4.1 Introduction
4.1.1 Market Taxonomy
4.1.2 Market Definition
4.1.3 Macro-Economic Factors Impacting the Market Growth
4.2 Cardiopulmonary Autotransfusion Equipment Market Dynamics
4.2.1 Market Drivers
4.2.2 Market Restraints
4.2.3 Market Opportunity
4.3 Cardiopulmonary Autotransfusion Equipment Market - Supply Chain Analysis
4.3.1 List of Key Suppliers
4.3.2 List of Key Distributors
4.3.3 List of Key Consumers
4.4 Key Forces Shaping the Cardiopulmonary Autotransfusion Equipment Market
4.4.1 Bargaining Power of Suppliers
4.4.2 Bargaining Power of Buyers
4.4.3 Threat of Substitution
4.4.4 Threat of New Entrants
4.4.5 Competitive Rivalry
4.5 Global Cardiopulmonary Autotransfusion Equipment Market Size & Forecast, 2020-2028
4.5.1 Cardiopulmonary Autotransfusion Equipment Market Size and Y-o-Y Growth
4.5.2 Cardiopulmonary Autotransfusion Equipment Market Absolute $ Opportunity
Chapter 5 Global Market Analysis and Forecast by Type
5.1 Introduction
5.1.1 Key Market Trends & Growth Opportunities by Type
5.1.2 Basis Point Share (BPS) Analysis by Type
5.1.3 Absolute $ Opportunity Assessment by Type
5.2 Market Size Forecast by Type
5.2.1 Unwashed ATS
5.2.2 Washed ATS
5.3 Market Attractiveness Analysis by Type
Chapter 6 Global Market Analysis and Forecast by Applications
6.1 Introduction
6.1.1 Key Market Trends & Growth Opportunities by Applications
6.1.2 Basis Point Share (BPS) Analysis by Applications
6.1.3 Absolute $ Opportunity Assessment by Applications
6.2 Market Size Forecast by Applications
6.2.1 Heart Surgery
6.2.2 Great Organ Transplant Surgery
6.2.3 Other Surgery
6.3 Market Attractiveness Analysis by Applications
Chapter 7 Global Cardiopulmonary Autotransfusion Equipment Market Analysis and Forecast by Region
7.1 Introduction
7.1.1 Key Market Trends & Growth Opportunities by Region
7.1.2 Basis Point Share (BPS) Analysis by Region
7.1.3 Absolute $ Opportunity Assessment by Region
7.2 Cardiopulmonary Autotransfusion Equipment Market Size Forecast by Region
7.2.1 North America
7.2.2 Europe
7.2.3 Asia Pacific
7.2.4 Latin America
7.2.5 Middle East & Africa (MEA)
7.3 Market Attractiveness Analysis by Region
Chapter 8 Coronavirus Disease (COVID-19) Impact
8.1 Introduction
8.2 Current & Future Impact Analysis
8.3 Economic Impact Analysis
8.4 Government Policies
8.5 Investment Scenario
Chapter 9 North America Analysis and Forecast
9.1 Introduction
9.2 North America Market Size Forecast by Country
9.2.1 U.S.
9.2.2 Canada
9.3 Basis Point Share (BPS) Analysis by Country
9.4 Absolute $ Opportunity Assessment by Country
9.5 Market Attractiveness Analysis by Country
9.6 North America Market Size Forecast by Type
9.6.1 Unwashed ATS
9.6.2 Washed ATS
9.7 Basis Point Share (BPS) Analysis by Type
9.8 Absolute $ Opportunity Assessment by Type
9.9 Market Attractiveness Analysis by Type
9.10 North America Market Size Forecast by Applications
9.10.1 Heart Surgery
9.10.2 Great Organ Transplant Surgery
9.10.3 Other Surgery
9.11 Basis Point Share (BPS) Analysis by Applications
9.12 Absolute $ Opportunity Assessment by Applications
9.13 Market Attractiveness Analysis by Applications
Chapter 10 Europe Analysis and Forecast
10.1 Introduction
10.2 Europe Market Size Forecast by Country
10.2.1 Germany
10.2.2 France
10.2.3 Italy
10.2.4 U.K.
10.2.5 Spain
10.2.6 Russia
10.2.7 Rest of Europe
10.3 Basis Point Share (BPS) Analysis by Country
10.4 Absolute $ Opportunity Assessment by Country
10.5 Market Attractiveness Analysis by Country
10.6 Europe Market Size Forecast by Type
10.6.1 Unwashed ATS
10.6.2 Washed ATS
10.7 Basis Point Share (BPS) Analysis by Type
10.8 Absolute $ Opportunity Assessment by Type
10.9 Market Attractiveness Analysis by Type
10.10 Europe Market Size Forecast by Applications
10.10.1 Heart Surgery
10.10.2 Great Organ Transplant Surgery
10.10.3 Other Surgery
10.11 Basis Point Share (BPS) Analysis by Applications
10.12 Absolute $ Opportunity Assessment by Applications
10.13 Market Attractiveness Analysis by Applications
Chapter 11 Asia Pacific Analysis and Forecast
11.1 Introduction
11.2 Asia Pacific Market Size Forecast by Country
11.2.1 China
11.2.2 Japan
11.2.3 South Korea
11.2.4 India
11.2.5 Australia
11.2.6 South East Asia (SEA)
11.2.7 Rest of Asia Pacific (APAC)
11.3 Basis Point Share (BPS) Analysis by Country
11.4 Absolute $ Opportunity Assessment by Country
11.5 Market Attractiveness Analysis by Country
11.6 Asia Pacific Market Size Forecast by Type
11.6.1 Unwashed ATS
11.6.2 Washed ATS
11.7 Basis Point Share (BPS) Analysis by Type
11.8 Absolute $ Opportunity Assessment by Type
11.9 Market Attractiveness Analysis by Type
11.10 Asia Pacific Market Size Forecast by Applications
11.10.1 Heart Surgery
11.10.2 Great Organ Transplant Surgery
11.10.3 Other Surgery
11.11 Basis Point Share (BPS) Analysis by Applications
11.12 Absolute $ Opportunity Assessment by Applications
11.13 Market Attractiveness Analysis by Applications
Chapter 12 Latin America Analysis and Forecast
12.1 Introduction
12.2 Latin America Market Size Forecast by Country
12.2.1 Brazil
12.2.2 Mexico
12.2.3 Rest of Latin America (LATAM)
12.3 Basis Point Share (BPS) Analysis by Country
12.4 Absolute $ Opportunity Assessment by Country
12.5 Market Attractiveness Analysis by Country
12.6 Latin America Market Size Forecast by Type
12.6.1 Unwashed ATS
12.6.2 Washed ATS
12.7 Basis Point Share (BPS) Analysis by Type
12.8 Absolute $ Opportunity Assessment by Type
12.9 Market Attractiveness Analysis by Type
12.10 Latin America Market Size Forecast by Applications
12.10.1 Heart Surgery
12.10.2 Great Organ Transplant Surgery
12.10.3 Other Surgery
12.11 Basis Point Share (BPS) Analysis by Applications
12.12 Absolute $ Opportunity Assessment by Applications
12.13 Market Attractiveness Analysis by Applications
Chapter 13 Middle East & Africa (MEA) Analysis and Forecast
13.1 Introduction
13.2 Middle East & Africa (MEA) Market Size Forecast by Country
13.2.1 Saudi Arabia
13.2.2 South Africa
13.2.3 UAE
13.2.4 Rest of Middle East & Africa (MEA)
13.3 Basis Point Share (BPS) Analysis by Country
13.4 Absolute $ Opportunity Assessment by Country
13.5 Market Attractiveness Analysis by Country
13.6 Middle East & Africa (MEA) Market Size Forecast by Type
13.6.1 Unwashed ATS
13.6.2 Washed ATS
13.7 Basis Point Share (BPS) Analysis by Type
13.8 Absolute $ Opportunity Assessment by Type
13.9 Market Attractiveness Analysis by Type
13.10 Middle East & Africa (MEA) Market Size Forecast by Applications
13.10.1 Heart Surgery
13.10.2 Great Organ Transplant Surgery
13.10.3 Other Surgery
13.11 Basis Point Share (BPS) Analysis by Applications
13.12 Absolute $ Opportunity Assessment by Applications
13.13 Market Attractiveness Analysis by Applications
Chapter 14 Competition Landscape
14.1 Cardiopulmonary Autotransfusion Equipment Market: Competitive Dashboard
14.2 Global Cardiopulmonary Autotransfusion Equipment Market: Market Share Analysis, 2019
14.3 Company Profiles (Details – Overview, Financials, Developments, Strategy)
14.3.1 Haemonetics
14.3.2 Medtronic
14.3.3 LivaNova
14.3.4 Fresenius Kabi
14.3.5 Terumo
14.3.6 Wandong Health Sources
14.3.7 Haemonetics
